How did DEPLOY correct the Moon Maestro FDA clearance date?
DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as 'December 2023 (specific K-number at cap-flag pending primary-source confirmation).' The framing was honest cap-flag discipline at the time: month-precision claim with K-number explicitly held at cap-flag pending primary-source-anchored verification. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. Both the K-number resolves (K240598) AND the date was off by six months (June 2024, not December 2023). The reconciliation operates as a worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus: cap-flag-honestly until primary source confirms; update + surface the change transparently via inline editorial-transparency footer + framework-in-action correction narrative when primary source surfaces. The catch is the discipline operating on itself. Per [DEPLOY's framework discipline](/explainers/how-deploy-verifies), recursive application of cap-flag + primary-source-anchored verification on DEPLOY's own published corpus + transparent surfacing of correction in entity-anchor footer + canonical worked-example narrative at correction-tier depth compounds editorial credibility at the operational-practice layer.
The cap-flag pattern at the K-number layer worked exactly as designed
The original framing held the K-number at explicit cap-flag tier: "specific K-number operates at verification-precision tier pending primary-source confirmation at any citation use." Readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. When primary source surfaced K240598 per Agent A FDA database research, the cap-flag resolved cleanly into verified state. Per cap-flag-as-trust-signal, this is the verified-by-disclosure editorial position operating as designed; framework reads cap-flagged claims at the appropriate verification depth.
The month-precision date claim was off by six months
The original framing read "December 2023" at the verification depth DEPLOY's available sourcing supported. Primary-source FDA database verification surfaces June 2024 as the actual clearance date. The date correction is the editorially substantive shift: trade-press references + secondary-industry coverage that informed the original framing operated at a different month-precision read than the primary-source FDA database. The cap-flag pattern at the K-number layer worked as designed; the month-precision date claim operated outside primary-source verification at the time of original framing and gets corrected as primary-source verification surfaces.
Recursive framework application: DEPLOY's framework on DEPLOY's own corpus
The Moon Maestro reconciliation differs structurally from the other Project C framework-in-action narratives (Figure 03 BMW, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value) which document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus. Aggregator-drift corrections demonstrate the framework's external-coverage discipline; recursive corrections demonstrate the framework's internal-corpus discipline. Both compound credibility; recursive application is structurally distinct editorial signal.
Inline editorial-transparency footer pattern operationalized
Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern: the entity-anchor body + AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure of the previous framing + the correction trail. Two-tier transparency discipline: entity anchor surfaces correction at audit-trail depth; this framework-in-action correction narrative documents the catch at editorial-anchor depth.
Surgical-cluster K-number precision compounding
Verified K240598 cleared June 2024 anchor compounds surgical-cluster precision at primary-source-FDA-database verification depth alongside parallel surgical-cluster K-number anchors. Mako K241517 + K242373 + ROSA per-procedure clearances + Maestro K240598 at editorial-anchor depth. Per surgical cluster framework, the K-number-anchored verification produces FDA-clearance-posture precision across the cluster at primary-source-FDA-database tier; aggregator framing referencing surgical platforms without K-number-anchored verification operates outside the cluster's verification-depth standard.
The original framing: honest cap-flag at month-precision
DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as:
"FDA 510(k) cleared December 2023. The specific K-number operates at primary-source verification posture; per cap-flag-as-trust-signal, the December 2023 clearance date is the load-bearing primary-source verification anchor; specific K-number citation operates at verification-precision tier pending primary-source confirmation at any citation use."
The framing was honest cap-flag discipline at the time. Month-precision claim (December 2023) was anchored at the verification depth DEPLOY's available sourcing supported; K-number was explicitly held at cap-flag tier pending primary-source-anchored verification at any citation use. The cap-flag was load-bearing: editorial readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth.
The discipline was operating correctly. The framing surfaced what was verified (month-precision claim) and what was held at cap-flag (specific K-number). Per cap-flag-as-trust-signal, honest cap-flag is the verified-by-disclosure editorial position; framework reads cap-flagged claims at the appropriate verification depth.
What primary-source verification surfaced
Per Agent A primary-source FDA database research, the actual verified state is:
- K-number: K240598. Resolved at primary-source-FDA-database verification depth.
- Clearance date: June 2024. Six months later than the original month-precision cap-flag.
The K-number resolution validates the cap-flag pattern (the K-number was honestly held at cap-flag pending primary-source verification; primary source surfaced K240598). The date correction operates as the editorial substantive shift: the original month-precision claim (December 2023) was incorrect at month precision; primary-source verification surfaces June 2024 as the actual clearance date.
Why the cap-flag pattern worked AND the date was off
The cap-flag pattern at the K-number layer worked exactly as designed. The K-number was explicitly held at cap-flag tier; readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. When primary source surfaced K240598, the cap-flag resolved cleanly into verified state.
The month-precision date claim is the editorially substantive layer where the original framing operated outside primary-source verification. The framing read "December 2023" at the verification depth DEPLOY's available sourcing supported, which turned out to be incorrect at month precision. Trade-press references + secondary-industry coverage that informed the original framing operated at a different month-precision read than the primary-source FDA database.
The reconciliation operates honestly. The cap-flag pattern at the K-number layer demonstrates the framework discipline operating as designed (honest cap-flag; primary source confirms; cap-flag resolves). The month-precision date correction demonstrates the framework discipline operating recursively on DEPLOY's own corpus (primary source surfaces; corpus updates + transparently surfaces the change).
The inline editorial-transparency footer pattern
Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern:
The entity-anchor body section "FDA 510(k) K240598 cleared June 2024" now contains an inline editorial-transparency note:
"Editorial-transparency note: this anchor previously framed clearance as 'December 2023 (specific K-number at cap-flag pending primary-source confirmation)'; primary-source FDA database verification surfaces K240598 cleared June 2024 (corrected June 4, 2026)."
The AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure of the previous framing + the correction trail. The two-tier transparency discipline operates: entity anchor surfaces correction at audit-trail depth; this framework-in-action correction narrative documents the catch at editorial-anchor depth.
The recursive framework application
The Moon Maestro reconciliation operates as a canonical worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus. Per DEPLOY's how-deploy-verifies methodology editorial canonical reference, the framework operates at four verification tiers. Applied to DEPLOY's own framing:
- Verified: month-precision clearance date claim at trade-press-referenced verification depth (the framing DEPLOY published).
- Cap-flagged: K-number held at cap-flag tier pending primary-source verification (the framing DEPLOY published).
- Primary-source surfaces: K240598 cleared June 2024 (Agent A primary-source FDA database research).
- Reconciliation: cap-flag resolves cleanly (K240598 verified); date correction surfaces honestly (December 2023 → June 2024); inline editorial-transparency footer documents the correction trail.
The framework discipline produces the correct answer with the previous framing surfaced honestly. The catch isn't an external correction (no aggregator caught DEPLOY's framing); the catch is DEPLOY's own primary-source-verification discipline operating on DEPLOY's own corpus.
How this differs from aggregator-drift corrections
The other Project C framework-in-action narratives (Figure 03 BMW, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value) document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus.
The structural distinction matters editorially. Aggregator-drift corrections demonstrate the framework's external-coverage discipline. Recursive corrections demonstrate the framework's internal-corpus discipline. Both compound credibility at the operational-practice layer; the recursive application is structurally distinct editorial signal.
Per DEPLOY's restraint-IS-the-product discipline, recursive framework application surfaces editorial honesty without overclaim. DEPLOY's own corpus operates under the same verified-vs-claimed framework discipline that DEPLOY applies to external coverage. The discipline cuts uniformly.
Why the correction matters editorially
The Moon Maestro reconciliation matters at three layers simultaneously:
- Operational-practice transparency: institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The reconciliation demonstrates the framework operating on DEPLOY's own corpus, surfacing the correction trail transparently.
- Cap-flag-pattern validation: the K-number was honestly held at cap-flag tier; primary source surfaced K240598; the cap-flag resolved cleanly. Cap-flag-as-trust-signal works as designed.
- Surgical-cluster precision compounding: Moon Maestro is the cohort's assistive-laparoscopy commercial-niche archetype; the verified K240598 cleared June 2024 anchor compounds surgical-cluster precision at primary-source-FDA-database verification depth alongside parallel surgical-cluster K-number anchors (Mako K241517 + K242373 + ROSA per-procedure clearances + Maestro K240598 at editorial-anchor depth).
For the entity-anchor canonical reference with full editorial-transparency footer, see what is Moon Surgical Maestro. For the parallel framework-in-action correction narratives, see Figure 03 BMW narrative correction, Physical Intelligence valuation correction, Covariant corporate-state correction, Red Cat Black Widow contract-value correction. For the methodology editorial canonical reference, see how DEPLOY verifies. For the surgical cluster framework, see the surgical robotics cluster.
Frequently asked
How did DEPLOY correct the Moon Maestro FDA clearance date?
DEPLOY's Moon Maestro entity anchor originally framed FDA 510(k) clearance as "December 2023 (specific K-number at cap-flag pending primary-source confirmation)". The framing was honest cap-flag discipline at the time: month-precision claim with K-number explicitly held at cap-flag pending primary-source-anchored verification. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. Both the K-number resolves (K240598) AND the date was off by six months (June 2024, not December 2023). The reconciliation operates as a worked example of DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own corpus.
Why was the original December 2023 framing honest cap-flag if it was wrong?
The cap-flag pattern operates at multiple layers. The K-number was explicitly held at cap-flag tier ("pending primary-source confirmation at any citation use"); readers + downstream consumers knew the K-number had not been verified at primary-source-FDA-database depth. The month-precision date claim was anchored at the verification depth DEPLOY's available sourcing supported; trade-press references + secondary-industry coverage informed the framing at month-precision read. The cap-flag at the K-number layer worked as designed; the month-precision date claim operated outside primary-source verification at the time of original framing. Per cap-flag-as-trust-signal, this is exactly how the framework is meant to operate: cap-flag-honestly until primary source confirms; surface the change transparently when primary source surfaces.
What is K240598 and where does the primary-source verification come from?
K240598 is the FDA 510(k) submission number for Moon Surgical Maestro, verified at primary-source FDA database depth per Agent A research. The K-number is the canonical FDA-database identifier for the 510(k) clearance; the K240598 designation + June 2024 clearance date both operate at primary-source-anchored verification tier. Per DEPLOY's framework on capability claims, the primary-source FDA database is the load-bearing verification anchor for FDA clearance claims; trade-press references + secondary-industry coverage operate at lower verification depth and get corrected as primary-source verification surfaces.
How does this correction differ from the other Project C correction narratives?
The Moon Maestro reconciliation differs structurally from the other Project C framework-in-action narratives. Figure 03 BMW narrative, Physical Intelligence valuation, Covariant corporate state, Red Cat Black Widow contract value all document DEPLOY's framework catching aggregator-drift in third-party coverage. The Moon Maestro reconciliation documents DEPLOY's framework operating recursively on DEPLOY's own published corpus. Aggregator-drift corrections demonstrate external-coverage discipline; recursive corrections demonstrate internal-corpus discipline.
What is the inline editorial-transparency footer pattern?
Per DEPLOY's editorial-discipline-at-rendered-surface, when DEPLOY rewrites or corrects published content, the rendered page surfaces the correction transparently via an inline editorial-transparency footer. The Moon Maestro entity anchor reconciliation applies the pattern: the entity-anchor body section "FDA 510(k) K240598 cleared June 2024" contains an inline editorial-transparency note disclosing the previous framing + the correction date + the cross-link to this framework-in-action narrative. The AEO TLDR + stats + callout + FAQ all surface the verified state with explicit editorial-transparency disclosure. Two-tier transparency discipline: entity anchor surfaces correction at audit-trail depth; this narrative documents the catch at editorial-anchor depth.
Why document this correction as a worked example?
Institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The recursive correction demonstrates the framework operating on DEPLOY's own corpus, surfacing the correction trail transparently. Three editorial layers compound: operational-practice transparency (DEPLOY's discipline cuts uniformly across external coverage + internal corpus); cap-flag-pattern validation (K-number cap-flag resolved cleanly; cap-flag-as-trust-signal works as designed); surgical-cluster precision compounding (K240598 cleared June 2024 anchor + parallel surgical-cluster K-number anchors at primary-source-FDA-database verification depth). Per DEPLOY's restraint-IS-the-product discipline, recursive framework application surfaces editorial honesty without overclaim.
Sources: Source: Original DEPLOY framing + Agent A primary-source FDA database verification + DEPLOY's verified-vs-claimed framework applied recursively. Recursive framework application + inline editorial-transparency footer pattern.
Explore the deployment map
See where these robots are verified operating, by place and type.
The Moon Maestro FDA clearance correction-as-worked-example documents DEPLOY's verified-vs-claimed framework applied recursively to DEPLOY's own published corpus. Original framing: 'FDA 510(k) cleared December 2023 (specific K-number at cap-flag pending primary-source confirmation).' Cap-flag at K-number layer worked as designed: honest cap-flag tier; readers + downstream consumers knew K-number had not been verified at primary-source-FDA-database depth. Primary-source FDA database research per Agent A surfaces K240598 cleared June 2024. The K-number resolution validates the cap-flag pattern (K-number held at cap-flag pending primary-source verification; primary source surfaces K240598; cap-flag resolves cleanly). The date correction operates as the editorially substantive shift: trade-press + secondary-industry references informed original month-precision framing; primary-source verification surfaces June 2024 (six months later than original December 2023 framing). Inline editorial-transparency footer pattern operationalized: entity-anchor body + AEO TLDR + stats + callout + FAQ all surface verified state with explicit editorial-transparency disclosure of previous framing + correction trail; two-tier transparency discipline (entity anchor at audit-trail depth + framework-in-action narrative at editorial-anchor depth). Structurally distinct from other Project C correction narratives: recursive framework application on DEPLOY's own corpus rather than external aggregator-drift catch. Three editorial layers compound: operational-practice transparency (discipline cuts uniformly across external coverage + internal corpus); cap-flag-pattern validation (cap-flag-as-trust-signal works as designed); surgical-cluster precision compounding (K240598 anchor + parallel Mako K241517+K242373 + ROSA per-procedure clearances at primary-source-FDA-database depth). How DEPLOY verifies →
Continue reading
What is Moon Surgical Maestro?
Entity anchor with inline editorial-transparency footer documenting correction trail; assistive-laparoscopy commercial-niche archetype + FDA 510(k) K240598 cleared June 2024.
Read article →
How DEPLOY corrected the Figure 03 BMW narrative
Parallel framework-in-action correction-narrative; three-layer aggregator-drift rejection on third-party coverage (vs recursive application on DEPLOY's own corpus).
Read article →
How DEPLOY corrected the Covariant corporate state
Parallel framework-in-action correction-narrative; opposing aggregator framings both rejected; primary-source verification surfaces continuing-but-diminished state.
Read article →
How DEPLOY verifies
Methodology editorial canonical reference; four-tier verification protocol + recursive framework application across DEPLOY's external + internal corpus.
Read article →
Compare alternatives
Moon Surgical Maestro entity anchorMoon Surgical registry companyHow DEPLOY verifies (methodology canonical)Surgical robotics cluster
More questions people ask
- How does DEPLOY distinguish da Vinci safety events at year-class-failure-mode-product-variant granularity?
- How does DEPLOY track supply-chain component failure modes chained to recall incidents?
- How does DEPLOY track the 2021 ROSA ONE Brain wrong-trajectory Class I recall?
- How does DEPLOY track the 2023 Asensus Senhance uncontrolled-arm Class I recall?
- How does DEPLOY track the 2026 da Vinci SureForm gray-reload Class I recall?
- What is a surgical robot?
Every robot coming to market, tracked and verified.
DEPLOY is the registry of physical AI: every company, model, deployment, and safety record, with the sources behind each one. Browse the humanoids, robotaxis, drones, and delivery robots being deployed right now.
Explore the DEPLOY registry →Most-tracked robots
In the registry